Trustees Of Indiana University

Trustees Of Indiana University, doing business as Indiana University Indianapolis (IU Indianapolis), is a prominent research institution and state-controlled institution of higher learning that serves as a major recipient of federal contract and grant awards. Located at 980 Indiana Ave, Indianapolis, IN 46202, IU Indianapolis is one of the largest medical schools in the United States and maintains an extensive portfolio of federally funded research, clinical trials, educational programs, and specialized service contracts. The institution has been registered in SAM.gov since August 9, 2005, and maintains an active federal vendor status with a current registration expiring September 27, 2026.

Through federal contract awards, IU Indianapolis has demonstrated substantial capacity to deliver diverse specialized services across multiple federal agencies. The institution has executed delivery order contracts with the National Oceanic and Atmospheric Administration (NOAA) for GlobalNOC network operations and management services, including a substantial delivery order valued at approximately $11.8 million for network operations renewal services through March 31, 2026. IU Indianapolis has also provided gene assays including retroviral vector copy number and replication competent retrovirus testing services to the National Heart, Lung, and Blood Institute through multiple delivery orders valued at $250,000 each. The Department of Veterans Affairs has awarded multiple contracts to IU Indianapolis, including delivery orders for long-acting reversible contraception (LARC) services to veterans in the Indianapolis area, IACUC program support services, and IBC biosafety services, with the VA contract portfolio exceeding $7.3 million in cumulative awards. Additionally, IU Indianapolis has received contracts from the National Institute of Allergy and Infectious Diseases for specialized research services. All contracts executed by IU Indianapolis have been competitively awarded without small business set-asides, reflecting the institution's open competition status and established vendor performance record.

IU Indianapolis maintains an extensive federal grant portfolio spanning multiple National Institutes of Health institutes and agencies, demonstrating leadership in biomedical research and training. The institution has received substantial project grants from the National Institute on Aging for research on Alzheimer's disease mechanisms, aging-related musculoskeletal remodeling, and cognitive decline prevention strategies, with individual awards exceeding $3 million. The National Institute of Diabetes and Digestive and Kidney Diseases has awarded multiple grants to IU Indianapolis for research on chronic kidney disease, renal fibrosis, vitamin D deficiency, and insulin resistance, with funding supporting both basic science investigations and clinical outcomes research. The National Heart, Lung, and Blood Institute has provided funding for cardiovascular research including studies on pulmonary hypertension, heart failure mechanisms, and cardiac regeneration. IU Indianapolis has also received grants from the National Cancer Institute for research on tumor biology and cancer immunotherapy, the National Institute of Neurological Disorders and Stroke for studies on neurodegenerative diseases and spinal cord injury, the National Institute of Allergy and Infectious Diseases for infectious disease and vaccine research, and the National Institute on Drug Abuse for substance use disorder research. The institution has established itself as a training hub through National Institute on Aging funding for the INSPIRE undergraduate research program and through National Institute of Nursing Research support for the LEADRS program on social determinants of health. Grant awards have frequently included sub-awards to partner institutions including Washington University, University of Pennsylvania, University of Pittsburgh, Purdue University, Northwestern University, and international collaborators, positioning IU Indianapolis as a lead research coordinator within collaborative research networks.

IU Indianapolis holds a single-award indefinite delivery contract (IDC) with the Department of Veterans Affairs, Veterans Integrated Service Network 10, with a ceiling value of $10 million and an ultimate completion date of March 31, 2030. This IDC represents a strategic partnership that has generated multiple delivery orders for diverse veteran health services. The vehicle has been utilized to issue delivery orders for long-acting reversible contraception (LARC) services, IACUC program support services, and other healthcare-related support functions for the Veterans Integrated Service Network 10. The contract structure allows for flexible task order issuance as service needs emerge, and the institution has demonstrated the capacity to execute large-scale delivery orders under this vehicle, with cumulative awards exceeding the $7.3 million threshold for documented performance. This indefinite delivery vehicle reflects the Veterans Affairs' confidence in IU Indianapolis' ability to provide sustained, specialized clinical and administrative support services to the Indiana veterans healthcare system.